Plasma Exchange May Treat Lung Cancer-linked LEMS and PCD

Plasma Exchange May Treat Lung Cancer-linked LEMS and PCD

295418

Plasma Exchange May Treat Lung Cancer-linked LEMS and PCD

Plasmapheresis, or plasma exchange, may be an effective way of managing small cell lung cancer-associated Lambert-Eaton myasthenic syndrome (LEMS) and paraneoplastic cerebellar degeneration (PCD), combined with peripheral nerve damage, a case report suggests. The simultaneous development of LEMS and PCD is usually associated with small cell lung cancer (SCLC) — an aggressive type of lung cancer most commonly seen in smokers. In the reported case, however, PCD developed several months after the onset of LEMS. As…

You must be logged in to read/download the full post.